Can Therapeutic-Range Chronic Phenytoin Administration Cause Cerebellar Ataxia?
Hye-Jin Moon, Beomseok Jeon
J Epilepsy Res. 2017;7(1):21-24. Published online 2017 Jun 30 DOI: https://doi.org/10.14581/jer.17004
Citations to this article as recorded by 
Ataxias: Hereditary, Acquired, and Reversible Etiologies
Chi-Ying R. Lin, Sheng-Han Kuo
Seminars in Neurology.2023; 43(01): 048. CrossRef
Investigation of the Roles of New Antiepileptic Drugs and Serum BDNF Levels in Efficacy and Safety Monitoring and Quality of Life: A Clinical Research
Meral Demir, Emel O. Akarsu, Hava O. Dede, Nerses Bebek, Sevda O. Yıldız, Betül Baykan, Ahmet G. Akkan
Current Clinical Pharmacology.2020; 15(1): 49. CrossRef
Irreversible Cerebellar Atrophy as a Complication of Short-Term Phenytoin Exposure: Clinical Improvement Following Discontinuation of the Culprit
Hussein Algahtani, Bader Shirah, Abdulrahman J. Alqahtani, Adnan Q. Al-Malki
Journal of Epilepsy Research.2020; 10(2): 96. CrossRef
Clinical and genetic spectrum of SCN2A-associated episodic ataxia
N. Schwarz, T. Bast, E. Gaily, G. Golla, K.M. Gorman, L.R. Griffiths, A. Hahn, J. Hukin, M. King, C. Korff, M.J. Miranda, R.S. Møller, B. Neubauer, R.A. Smith, T. Smol, P. Striano, B. Stroud, M. Vaccarezza, G. Kluger, H. Lerche, W. Fazeli
European Journal of Paediatric Neurology.2019; 23(3): 438. CrossRef